AEON Biopharma, Inc. Share Price Nasdaq
Equities
AEON
US00775E1029
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.05 USD | 0.00% | 0.00% | 0.00% |
12/04 | AEON Biopharma, Inc. announced that it has received $15 million in funding from Daewoong Pharmaceutical Co., Ltd | CI |
01/04 | Sector Update: Health Care Stocks Slide Late Afternoon | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 192M 15.98B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.81% |
1st Jan change | Capi. | |
---|---|---|
-2.87% | 103B | |
+1.57% | 95.28B | |
+1.46% | 22.15B | |
-16.19% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.26% | 16.05B | |
+5.65% | 13.68B | |
+33.28% | 12.17B |
- Stock Market
- Equities
- AEON Stock
- AEON Stock